A heterocyclic strategy for regulating the proportion of type I and type II photodynamic therapy-Reference-Cited by-同舟云学术

A heterocyclic strategy for regulating the proportion of type I and type II photodynamic therapy

Published:2024 Issue:17 Volume:8 Page:2866-2873
ISSN:2052-1537
Container-title:Materials Chemistry Frontiers
language:en
Short-container-title:Mater. Chem. Front.

Author:

Tang Hui¹²,Ma Ning¹²,Liu Xiaochun¹²,Wu Shiyu¹²,Li Hairong¹²,Chen Kangyao¹²,Jiang Yitong¹²,Zhang Yahui¹²^ORCID,Wang Zhouyu¹²,Yu Xiaoqi¹³^ORCID

Affiliation:

1. Department of Chemistry, School of Science, Xihua University, Chengdu, 610039, China

2. Sichuan Engineering Research Center for Molecular Targeted Diagnostic & Therapeutic Drugs, Chengdu, 610039, China

3. Key Laboratory of Green Chemistry and Technology of Ministry of Education, College of Chemistry, Sichuan University, Chengdu 61064, China

Abstract

(Yield of ROS)TPO > (yield of ROS)TPS > (yield of ROS)TPP, (proportion of type I ROS)TPO > (proportion of type I ROS)TPS > (proportion of type I ROS)TPP.

Funder

Sichuan Province Science and Technology Support Program

National Key Research and Development Program of China

Opening Project of Key Laboratory of Green Chemistry of Sichuan Institutes of Higher Education

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/QM/D4QM00399C

Reference50 articles.

1. Supramolecular Photosensitizer Enables Oxygen-Independent Generation of Hydroxyl Radicals for Photodynamic Therapy

2. Fluorescence resonance energy transfer-based drug delivery systems for enhanced photodynamic therapy

3. Substitution Activated Precise Phototheranostics through Supramolecular Assembly of AIEgen and Calixarene

4. Overcoming the Achilles' heel of photodynamic therapy